China SXT Pharmaceuticals, Inc. financial data

Symbol
SXTC on Nasdaq
Industry
Pharmaceutical Preparations
Location
178 Taidong Road North, Taizhou, China
State of incorporation
Virgin Islands, British
Fiscal year end
March 31
Latest financial report
20-F - Q1 2024 - Aug 13, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 0 shares -100%
Common Stock, Shares, Outstanding 2.22M shares +385%
Common Stock, Value, Issued 4.35M USD +376%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.1M USD -30.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.31M USD -2.22%
Inventory, Net 795K USD +49.6%
Assets, Current 14.2M USD -27.1%
Deferred Income Tax Assets, Net 30.7K USD
Property, Plant and Equipment, Net 329K USD -65.8%
Operating Lease, Right-of-Use Asset 306K USD
Intangible Assets, Net (Excluding Goodwill) 19.1K USD -31.5%
Assets 23.1M USD -21.7%
Accounts Payable, Current 1.28M USD -7.14%
Contract with Customer, Liability, Current 188K USD +13.4%
Liabilities, Current 8.9M USD -38.6%
Operating Lease, Liability, Noncurrent 248K USD
Liabilities 9.2M USD -38.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.03M USD -419%
Retained Earnings (Accumulated Deficit) -24.7M USD -14.3%
Stockholders' Equity Attributable to Parent 13.9M USD -5.18%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.9M USD +7.96%
Liabilities and Equity 23.1M USD -21.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 2.22M shares +385%
Common Stock, Par or Stated Value Per Share 2 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.1M USD -30.5%
Deferred Tax Assets, Valuation Allowance 1.25M USD +42.6%
Operating Lease, Liability 236K USD -22.9%
Property, Plant and Equipment, Gross 2.75M USD -4.64%
Operating Lease, Liability, Current 58.1K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 906K USD +63.8%
Additional Paid in Capital 35.9M USD +10.4%
Operating Leases, Future Minimum Payments, Due in Two Years 78.9K USD +3.35%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 78.9K USD +3.35%
Deferred Tax Assets, Net of Valuation Allowance 564K USD
Operating Leases, Future Minimum Payments, Due in Three Years 78.9K USD +3.35%
Operating Leases, Future Minimum Payments Due 454K USD -12%